Corporate Bond Index Etf Ishares logo

Corporate Bond Index Etf Ishares(LQD)

$109.62-1.02%

Market is closed - opens 7 PM, 22 Oct 2024

Insights

  • Corporate Bond Index Etf Ishares is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Corporate Bond Index Etf Ishares stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Corporate Bond Index Etf Ishares stock is in a downtrend↘️
  • Based on analysis of the Pivot Points, the current market trend for Corporate Bond Index Etf Ishares stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
38.37
Neutral
Stochastic
13.01, 25.09
Neutral
Ultimate Oscillator
42.32
Neutral
Stochastic Relative Strength Index
30.57, 31.95
Neutral
Moving Average Convergence Divergence
-0.37, -0.22
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
111.02
Sell
20
111.92
Sell
50
111.98
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
111.24
Sell
20
111.62
Buy
50
111.47
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
111.02
Neutral
20
111.96
Neutral
50
112.03
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
110.81
Sell
20
111.19
Sell
50
112.38
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
110.81
Buy
20
110.63
Sell
50
112.03
Sell

Pivot

Pivot

Value

Resistance L3
111.67
Resistance L2
111.49
Resistance L1
111.19
Pivot Point
111.01
Support L1
110.7
Support L2
110.52
Support L3
110.22

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.